AstraZeneca plc Stock
.png?locale=us "FinanceClub_UoM")
AstraZeneca plc Stock
A loss of -2.420% shows a downward development for AstraZeneca plc.
AstraZeneca plc is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of €110.00 there is a slightly positive potential of 9.890% for AstraZeneca plc compared to the current price of €100.10.
Our community identified positive and negative aspects for AstraZeneca plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the AstraZeneca plc stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of AstraZeneca plc in the next few years
Pros
2
Could be worthwhile Investment >10% per year
2
Small cyclical dependencies
1
Standard Investments for future growth
Cons
1
Higher risks for its business
Performance of AstraZeneca plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AstraZeneca plc | -2.420% | 8.207% | 2.478% | 6.966% | 23.710% | 55.213% | 72.371% |
| GlaxoSmithKline plc | -0.970% | -0.121% | -4.948% | 1.064% | 7.833% | -3.819% | -13.057% |
| Merck KGaA | -3.160% | -0.941% | -2.406% | 56.260% | 39.470% | 120.548% | 104.639% |
| Merck & Co. Inc. | 0.080% | 2.865% | -3.531% | -12.003% | -5.377% | 4.717% | 14.340% |
Comments
Considering AZN's strong performance and the estimated growth of the sector due to COVID-19, we issue a buy recommendation.
Other discussions about AstraZeneca plc Stock
Trading AstraZeneca plc
Trading AstraZeneca plc
